COMPTON JOHN G. enters 20/20 BIOLABS, INC. with 6.67K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives

COMPTON JOHN G.

Filed: 2/17/2026ACC: 0001213900-26-017551

InsiderCOMPTON JOHN G.CIK 2107487

→

Issuer20/20 BIOLABS, INC.CIK 1139685

Director

Since Feb 2026

6.67K

Baseline shares

100% direct

6.67K

Direct ownership

1 position

268.24K

Derivative underlying

7 instruments

Security positions

All direct

Non-Derivative Holdings1

Common Stock

Direct

Shares owned6.67K

Total

6.67K direct6.67K

Security Title	Shares Owned	Ownership Type
Common Stock	6.67K	Direct
Total	6.67K	6.67K direct

Derivative Holdings7

Stock Option

Direct

Underlying security

Common Stock

Underlying shares

37.58K

Shares owned

N/A

Exercise price

1.0643

Expiration

—

Exercise window

—

Stock Option

Direct

Underlying security

Common Stock

Underlying shares

76.63K

Shares owned

N/A

Exercise price

1.044

Expiration

—

Exercise window

—

Series A-2 Preferred Stock

Direct

Underlying security

Common Stock

Underlying shares

7.67K

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Stock Option

Direct

Underlying security

Common Stock

Underlying shares

48.78K

Shares owned

N/A

Exercise price

0.82

Expiration

—

Exercise window

—

Stock Option

Direct

Underlying security

Common Stock

Underlying shares

30K

Shares owned

N/A

Exercise price

1.74

Expiration

—

Exercise window

—

Stock Option

Direct

Underlying security

Common Stock

Underlying shares

30K

Shares owned

N/A

Exercise price

2.55

Expiration

—

Exercise window

—

Stock Option

Direct

Underlying security

Common Stock

Underlying shares

37.58K

Shares owned

N/A

Exercise price

1.0643

Expiration

—

Exercise window

—

Total

Underlying

268.24K

Owned

0.00

Security	Underlying	Exercise Price	Exercise Window	Expiration	Underlying Shares	Shares Owned
Stock Option Direct	Common Stock	1.0643	—	—	37.58K	N/A
Stock Option Direct	Common Stock	1.044	—	—	76.63K	N/A
Series A-2 Preferred Stock Direct	Common Stock		—	—	7.67K	N/A
Stock Option Direct	Common Stock	0.82	—	—	48.78K	N/A
Stock Option Direct	Common Stock	1.74	—	—	30K	N/A
Stock Option Direct	Common Stock	2.55	—	—	30K	N/A
Stock Option Direct	Common Stock	1.0643	—	—	37.58K	N/A
Total					268.24K	0.00